Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1974 Apr 20;2(5911):145–149. doi: 10.1136/bmj.2.5911.145

Assessment of Coagulation and Fibrinolysis in Pre-eclampsia

S M Wood, D Burnett, A M Picken, G W Farrell, P Wolf
PMCID: PMC1610344  PMID: 4596483

Abstract

A method is described for distinguishing coagulation from fibrinolysis by three estimates of fibrinogen. This “fibrinogen series” together with plasma antithrombin and urinary urokinase have been compared in pregnant patients with venous thrombosis and pre-eclampsia. Evidence is presented for active coagulation during deterioration of the pre-eclampsia state and for enhanced fibrinolysis during improvement.

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonnar J., Davidson J. F., Pidgeon C. F., McNicol G. P., Douglas A. S. Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J. 1969 Jul 19;3(5663):137–140. doi: 10.1136/bmj.3.5663.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Farrell G. W., Wolf P. A batch method for estimating thrombin clottable fibrinogen. J Clin Pathol. 1973 Oct;26(10):764–769. doi: 10.1136/jcp.26.10.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Farrell G. W., Wolf P. Immunoephelometric determination of fibrinogen and its derivatives in plasma. J Immunol Methods. 1972 May;1(3):217–229. doi: 10.1016/0022-1759(72)90001-4. [DOI] [PubMed] [Google Scholar]
  4. Farrell G. W., Wolf P. The measurement of fibrinogen and its derivatives. 3. Thrombin clottable fibrinogen estimates in the presence of epsilon amino caproic acid, fibrinogen and fibrin degradation products. Med Lab Technol. 1971 Jul;28(3):328–336. [PubMed] [Google Scholar]
  5. Henderson A. H., Pugsley D. J., Thomas D. P. Fibrin degradation products in pre-eclamptic toxaemia and eclampsia. Br Med J. 1970 Sep 5;3(5722):545–547. doi: 10.1136/bmj.3.5722.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Howie P. W., Prentice C. R., McNicol G. P. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw. 1971 Nov;78(11):992–1003. doi: 10.1111/j.1471-0528.1971.tb00216.x. [DOI] [PubMed] [Google Scholar]
  7. PRITCHARD J. A., RATNOFF O. D., WEISMAN R., Jr Hemostatic defects and increased red cell destruction in pre-eclampsia and eclampsia. Obstet Gynecol. 1954 Aug;4(2):159–164. [PubMed] [Google Scholar]
  8. Page E. W. On the pathogenesis of pre-eclampsia and eclampsia. J Obstet Gynaecol Br Commonw. 1972 Oct;79(10):883–894. doi: 10.1111/j.1471-0528.1972.tb12184.x. [DOI] [PubMed] [Google Scholar]
  9. SHAINOFF J. R., PAGE I. H. Significance of cryoprofibrin in fibrinogen-fibrin conversion. J Exp Med. 1962 Nov 1;116:687–707. doi: 10.1084/jem.116.5.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Wardle E. N., Menon I. S. Fibrinolysis in pre-eclamptic toxaemia of pregnancy. Br Med J. 1969 Jun 7;2(5657):625–627. doi: 10.1136/bmj.2.5657.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wolf P., Farrell G. W., Walton K. W. The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis. J Clin Pathol. 1972 Jan;25(1):36–44. doi: 10.1136/jcp.25.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES